London, United Kingdom -29 April 2024 - Rapid Nutrition PLC (Euronext Growth: ALRPD): Rapid Nutrition PLC a natural wellness company focused on evidenced-based nutrition, is pleased to disclose the audited financial outcomes for the fiscal year 2023.

Key financial highlights from the audited 2023 results include:

  • Direct-to-Consumer (DTC) Channels Drive Revenue Growth: Rapid Nutrition achieves significant financial milestones with strong online revenue growth through DTC channels in FY2023.
  • Robust Gross Profit Margin Amid Market Challenges: Despite market adversities, Rapid Nutrition maintained a robust gross profit margin in FY2023, underscoring its commitment to operational efficiency.
  • Significant Liabilities Decrease and Cash Position Boost: Rapid Nutrition achieved an 83% reduction in liabilities and a 107% increase in cash position compared to the previous year, positioning the company for sustained growth and financial solidity in the upcoming fiscal period.

Investors and stakeholders can access the full report on the company website.

About Rapid Nutrition

Rapid Nutrition is a leading health and wellness company committed to providing innovative solutions for a healthier world. With a focus on research-backed formulas, we empower individuals to optimize their well-being and face life's challenges with confidence.

Investor Relations Contact:

ir@rnplc.com

Disclaimer

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).

Attachments

  • Original Link
  • Permalink

Disclaimer

Rapid Nutrition plc published this content on 28 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 April 2024 01:08:01 UTC.